Geode Capital Management, LLC Celldex Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,534,916 shares of CLDX stock, worth $31.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,534,916
Previous 1,540,513
0.36%
Holding current value
$31.3 Million
Previous $52.3 Million
25.88%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$183 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$103 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$95.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$79.3 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$76.6 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $955M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...